186 related articles for article (PubMed ID: 23861647)
1. A review of eslicarbazepine acetate for the adjunctive treatment of partial-onset epilepsy.
Singh RP; Asconapé JJ
J Cent Nerv Syst Dis; 2011; 3():179-87. PubMed ID: 23861647
[TBL] [Abstract][Full Text] [Related]
2. Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy.
Tambucci R; Basti C; Maresca M; Coppola G; Verrotti A
Neuropsychiatr Dis Treat; 2016; 12():1251-60. PubMed ID: 27307737
[TBL] [Abstract][Full Text] [Related]
3. Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.
Lattanzi S; Brigo F; Cagnetti C; Verrotti A; Zaccara G; Silvestrini M
Core Evid; 2018; 13():21-31. PubMed ID: 29563858
[TBL] [Abstract][Full Text] [Related]
4. Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures.
Brown ME; El-Mallakh RS
Ther Clin Risk Manag; 2010 Apr; 6():103-9. PubMed ID: 20421910
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures.
Abou-Khalil B; Klein P; Shah A; Ryvlin P; Specchio LM; Gama H; Rocha F; Blum D; Grinnell T; Cheng H; Jung J
Epilepsy Res; 2018 Nov; 147():80-86. PubMed ID: 30278294
[TBL] [Abstract][Full Text] [Related]
6. Update on treatment of partial onset epilepsy: role of eslicarbazepine.
Rauchenzauner M; Luef G
Neuropsychiatr Dis Treat; 2010 Nov; 6():723-30. PubMed ID: 21127691
[TBL] [Abstract][Full Text] [Related]
7. Eslicarbazepine acetate (BIA 2-093).
Almeida L; Soares-da-Silva P
Neurotherapeutics; 2007 Jan; 4(1):88-96. PubMed ID: 17199020
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of eslicarbazepine: current evidence.
Zaccara G; Giovannelli F; Cincotta M; Carelli A; Verrotti A
Drug Des Devel Ther; 2015; 9():781-9. PubMed ID: 25709402
[TBL] [Abstract][Full Text] [Related]
9. Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
Shorvon SD; Trinka E; Steinhoff BJ; Holtkamp M; Villanueva V; Peltola J; Ben-Menachem E
J Neurol; 2017 Mar; 264(3):421-431. PubMed ID: 28101651
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
[TBL] [Abstract][Full Text] [Related]
11. Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.
Sperling MR; Abou-Khalil B; Harvey J; Rogin JB; Biraben A; Galimberti CA; Kowacs PA; Hong SB; Cheng H; Blum D; Nunes T; Soares-da-Silva P;
Epilepsia; 2015 Feb; 56(2):244-53. PubMed ID: 25528898
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
Sunkaraneni S; Ludwig EA; Passarell JA; Blum D; Grinnell T; Fiedler-Kelly J
J Clin Pharmacol; 2018 Jul; 58(7):927-938. PubMed ID: 29528499
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and drug interactions of eslicarbazepine acetate.
Bialer M; Soares-da-Silva P
Epilepsia; 2012 Jun; 53(6):935-46. PubMed ID: 22612290
[TBL] [Abstract][Full Text] [Related]
14. Eslicarbazepine acetate for partial-onset seizures.
Rauchenzauner M; Luef G
Expert Rev Neurother; 2011 Dec; 11(12):1673-81. PubMed ID: 22091592
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of epilepsy: newly approved and developmental agents.
Stephen LJ; Brodie MJ
CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
[TBL] [Abstract][Full Text] [Related]
16. Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy.
Wechsler RT; Radtke RA; Smith M; Vossler DG; Strom L; Trinka E; Cheng H; Grinnell T; Blum D; Vieira M; Moreira J; Rocha F
Epilepsia; 2019 Jul; 60(7):1341-1352. PubMed ID: 31260089
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Toledano R; Jovel CE; Jiménez-Huete A; Bayarri PG; Campos D; Gomariz EL; Giráldez BG; García-Morales I; Falip M; Agredano PM; Palao S; Prior MJAA; Pascual MRQ; Navacerrada FJ; González FJL; Ojeda J; Sáez AA; Bermejo PE; Gil-Nagel A
Epilepsy Behav; 2017 Aug; 73():173-179. PubMed ID: 28641170
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study.
Villanueva V; Serratosa JM; Guillamón E; Garcés M; Giráldez BG; Toledo M; Salas-Puig J; López González FJ; Flores J; Rodríguez-Uranga J; Castillo A; Mauri JA; Camacho JL; López-Gomáriz E; Giner P; Torres N; Palau J; Molins A
Epilepsy Res; 2014 Sep; 108(7):1243-52. PubMed ID: 24908564
[TBL] [Abstract][Full Text] [Related]
19. Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
Lawthom C; Peltola J; McMurray R; Dodd E; Villanueva V
Neurol Ther; 2018 Dec; 7(2):195-206. PubMed ID: 30251237
[TBL] [Abstract][Full Text] [Related]
20. Eslicarbazepine acetate for the treatment of partial epilepsy.
Zelano J; Ben-Menachem E
Expert Opin Pharmacother; 2016 Jun; 17(8):1165-9. PubMed ID: 27149439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
